- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)
Browse
Administrators only